Thursday - July 23, 2026

Eczema Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Eczema Pipeline Insights 2026” Report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics … Continue reading

Sleep Tech Devices Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight

The latest market forecast report provides an in-depth analysis of the Sleep Tech Devices Market, offering comprehensive insights into the market revenue trends, segmentation, and product landscape. The report delves into key Sleep Tech Devices Market statistics, highlighting the current … Continue reading

Prader-Willi Syndrome Market is Projected to Grow Significantly by 2036 Owing to the Launch of Novel Hyperphagia Therapies and Advancements in Disease Management | DelveInsight

The Prader-Willi Syndrome (PWS) market is witnessing steady growth, driven by increasing disease awareness, improving diagnostic capabilities, wider adoption of growth hormone therapy, and rising demand for treatments targeting hyperphagia. The launch of new therapies and the advancement of promising … Continue reading

Cold Agglutinin Disease Market is Projected to Witness Significant Growth by 2036 Owing to Rising Disease Awareness and Continued Adoption of Targeted Complement Inhibition | DelveInsight

The Cold Agglutinin Disease (CAD) market is witnessing steady growth, driven by increasing disease awareness, improving diagnosis rates, growing adoption of targeted complement inhibitors, and rising demand for therapies that reduce hemolysis and improve patient outcomes. Expanding access to disease-specific … Continue reading

Morquio Syndrome Market is Expected to Witness Significant Growth by 2036 Driven by Improved Diagnosis, Long-term Enzyme Replacement Therapy Adoption, and Advances in Rare Disease Management | DelveIn

The Morquio Syndrome market is witnessing steady growth, driven by increasing awareness and diagnosis of rare genetic disorders, wider adoption of enzyme replacement therapy (ERT), expanding newborn screening programs, and supportive reimbursement policies. Continued advances in disease management, emphasis on … Continue reading